GSK to sell two vaccines in $1.1 billion deal to focus on newer treatments

GlaxoSmithKline will sell two travel vaccines to Bavarian Nordic for up to 955 million euros ($1.1 billion), the British firm said on Monday, as it looks to bolster its push into the lucrative cancer drug market.

Source: Reuters: Health - October 21, 2019 Category: Consumer Health News Tags: healthNews Source Type: news